Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years. Segal EB, Wheless JW, Zafar M, Shih EK, et al. Epilepsia 2025 Jul 12. doi: 10.1111/epi.18473.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Segal EB, Wheless JW, Zafar M, Shih EK, et al. Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years. Epilepsia 2025 Jul 12. doi: 10.1111/epi.18473.
PMID: 40650667